Acha-Sagredo, Amelia
Uko, Bubaraye
Pantazi, Paschalia
Bediaga, Naiara G.
Moschandrea, Chryssanthi
Rainbow, Lucille
Marcus, Michael W.
Davies, Michael P. A.
Field, John K.
Liloglou, Triantafillos
Funding for this research was provided by:
Roy Castle Lung Cancer Foundation (2014/05/Liloglou, 2014/05/Liloglou)
Article History
Received: 13 June 2019
Revised: 16 December 2019
Accepted: 15 January 2020
First Online: 5 February 2020
Ethics approval and consent to participate
: Ethical approval was obtained from the Liverpool Central Research Ethics Committee (ref 97/141). All patients were recruited following voluntary informed consent, and the study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: Microarray data have been deposited in the Gene Expression Omnibus (GEO) database (GSE130740).
: The authors declare no competing interests.
: This research was supported by the Roy Castle Lung Cancer Foundation, UK (Grant no 2014/05/Liloglou) and a Roy Castle Lung Cancer Senior Fellowship (MPAD).